Gram negative bacteria screening method with horseshoe crab amebocyte lysate (LAL)

• US 4,717,658 A
• Filed: 12/03/1985
• Issued: 01/05/1988
• Est. Priority Date: 12/03/1985
• Status: Expired due to Fees

• Current Assignee: Miles, Inc. (Bayer AG)
• Original Assignee: Miles, Inc. (Bayer AG)
• Inventors: Michaels, Angela A.
• Primary Examiner(s): NOT, DEFINED
• Application Number:
  US06/803,963
• Time in Patent Office: 763 Days
• Field of Search: 436/502, 435/4, 435/19
• US Class Current: 435/18
• CPC Class Codes: C07K 5/0808 the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
• CPC Class Codes: G01N 33/579 involving limulus lysate
• CPC Class Codes: Y10S 930/28 Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin

Abstract

A screening method for the determination of 10⁴ gram negative bacteria per milliliter of an undiluted urine sample and a unitary screening test device for the determination of at least 10⁵ gram negative bacteria per milliliter of an undiluted urine sample. The method and test device make use of Limulus amebocyte lysate (LAL) and a synthetic substrate containing a chromogenic or fluorogenic leaving group capable of being cleaved by activated lysate. This screening method and unitary screening device provide a quick, convenient, inexpensive indication of the possible presence of a urinary tract infection caused by gram negative bacteria.

Claims

1. A gram negative bacteria screening method for determining the presence of at least 10⁴ gram negative bacteria cells per milliliter of a urine sample, comprising the steps of:

(a) adding an undiluted urine sample to be tested to a test tube containing horseshoe crab amebocyte lysate and a first buffer capable of resisting a pH change in the pH range of from about 6.3 to about 7.5, to form a test tube mixture wherein the concentration of lysate is at least 3.5 milligrams per milliliter of the test tube mixture formed;

(b) incubating the test tube mixture for a time sufficient to activate the lysate;

(c) contacting a test device with the activated test tube mixture, said test device comprising a carrier matrix incorporated with a synthetic peptide substrate containing a chromogenic or fluorogenic leaving group capable of being cleaved by the activated lysate and a second buffer capable of resisting pH change in the pH range of from about 8.0 to about 8.9;

(d) removing the contacted test device; and

(e) determining the concentration of cleaved leaving group.

2. The screening method of claim 1 in which the lysate is Limulus amebocyte lysate.

3. The screening method of claim 1 in which the carrier matrix is additionally incorporated with a divalent cation.

4. The screening method of claim 1 in which divalent cation is additionally added to the test tube prior to incubation.

5. The screening method of claim 3 in which the divalent cation is selected from the group consisting of calcium, magnesium, strontium and manganese.

6. The screening method of claim 5 in which the divalent cation is calcium.

7. The screening method of claim 1 in which the leaving group is chromogenic.

8. The screening method of claim 1 in which the chromogenic leaving group is 3-aminoindole and the carrier matrix is additionally incorporated with a diazonium salt.

9. The screening method of claim 8 in which the carrier matrix is pretreated with an interpolymer of methylvinyl ether and maleic anhydride.

10. A unitary gram negative bacteruria screening device for determining the presence of at least 10⁵ gram negative bacteria per milliliter of a urine sample, comprising:

(a) a carrier matrix; and

(b) a test composition incorporated with the carrier matrix, which composition includes horseshoe crab amebocyte lysate, a divalent cation, a synthetic peptide substrate with a chromogenic or fluorogenic leaving group capable of being cleaved by the lysate, a buffer component capable of resisting a pH change in a pH range of from about 7.5 to about 8.5 and a stabilizing component capable of stabilizing the lysate.

11. The unitary screening device of claim 10 in which the lysate is Limulus amebocyte lysate.

12. The unitary screening device of claim 10 in which the leaving group is chromogenic.

13. The unitary screening device of claim 10 in which the divalent cation is selected from the group consisting of calcium, magnesium, strontium and manganese.

14. The unitary screening device of claim 10 in which the stabilizing component is a member selected from the group consisting of gelatin, interpolymers, of methylvinyl ether and maleic anhydride and polyethylene glycol ρ

-isooctylphenyl ether.

15. The unitary screening device of claim 12 in which the chromogenic leaving group is p-nitroaniline.

16. A method for preparing a unitary gram negative bacteruria unitary test device for determining the presence of at least 10⁵ gram negative bacteria per milliliter of a urine sample, comprising the steps of:

(a) incorporating a carrier matrix with a stabilizing component capable of stabilizing horseshoe crab amebocyte lysate;

(b) drying; and

(c) incorporating the dried matrix with a test composition including horseshoe crab amebocyte lysate, a divalent cation, a synthetic peptide substrate with a chromogenic or fluorogenic leaving group capable of being cleaved by the lysate and a buffer component capable of resisting a pH change in a pH range of from about 7.5 to about 8.5; and

(d) drying.